Polyprev: Study to Compare Fecal Immunochemical Test With Endoscopic Surveillance After Advanced Adenoma Resection in Fecal Immunochemical Test Colorectal Cancer Screening Programs.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-65
SponsorFundacin Biomedica Galicia Sur

About this trial

Colorectal cancer (CRC) screening programs have been implemented to reduce the burden of the disease. When an advanced colonic lesions is detected, it is recommended to perform endoscopic surveillance with different intervals between explorations. Although the reduction in CRC incidence, endoscopic surveillance is producing a considerable increase in the number of colonoscopies. However, participation in CRC screening programs based on the fecal immunochemical test (FIT) could be a non inferior alternative to endoscopic surveillance.

Based on this hypothesis, the research group have designed a randomized clinical trial within the population CRC screening programs to compare FIT surveillance to endoscopic surveillance in patients with advanced lesions resected.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Individuals aged 50 to 65 years.

Individuals with at least one advanced adenoma (tubulovillous or villous histology, high grade dysplasia or ≥ 10mm), and / or at least three non-advanced adenomas detected and resected completely within the population-based CRC screening program.

Disqualifiers

Personal history of CRC.

Colonic lesion ≥10mm resected without histological diagnosis.

More than 10 adenomas in baseline colonoscopy.

Serrated polyposis syndrome.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Annual FIT

    Diagnostic test

    Patients will be offered an annual FIT and colonoscopy will be performed if fecal hemoglobin concentration is ≥10µg / g of feces. After performing a colonoscopy the FIT will be sent to the patient: * After one year if the unscheduled colonoscopy has been incomplete or a lesion requiring endoscopic surveillance has been completely resected. * After five years if the colonoscopy has evaluated the entire mucosa, it is normal or with lesions that do not require endoscopic surveillance (1-2 non-advanced adenomas).

  • Endoscopic surveillance.

    Procedure/Surgery

    First surveillance colonoscopy will be performed in three-year time. If an advanced adenoma or at least three non-advanced adenomas are detected, colonoscopy will be repeated after 3 years. In contrast, if colonoscopy is normal or 1-2 non-advanced adenomas are detected, colonoscopy will be repeated after 5 years.

Treatment groups

3,788 Participants
are divided into 2 treatment groups
Group A: Group IExperimental treatment 1 intervention
Group B: Group IIActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Rate of invasive CRC

It is the main outcome of the study. Invasive CRC is defined as colonic adenocarcinoma that invades the submucosa. Adenocarcinomas in situ and intramucosal carcinomas will not be considered as invasive CRC.

Time frame
10 years
2

Rate of interval CRC

Interval CRC is defined as the CRC detected between two organized surveillance (FIT or colonoscopy).

Time frame
10 years
3

Mortality

The deaths and their cause will be collected: associated with CRC, associated with adverse effects of screening or unrelated.

Time frame
10 years
4

Rate of advanced colonic lesions

Advanced colonic lesions will be defined as advanced adenomas (at least 10mm, hairy histology or high grade dysplasia) or advanced serrated lesions (at least 10mm or with dysplasia).

Time frame
10 years

Secondary outcomes

1

CRC, adenoma and advanced serrated lesions at three years

Detection of CRC, adenoma and advanced serrated lesion will be collected at 3 years of follow-up.

Time frame
3 years
2

Physical activity

We will use the International Physical Activity. Questionnaire (IPAQ) to mesure physical activity.

Time frame
3 years
3

Mediterranean lifestyle

We will use the Mediterranean Lifestyle index (MEDLIFE) to measure overall adherence to the Mediterranean lifestyle.

Time frame
3 years
4

Preferences of the subjects

We will use a survey with vignette questions to evaluate the values and preferences of the subjects regarding surveillance.

Time frame
2 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.